Upper Abdominal Surgery
Conditions
Brief summary
The investegators aimed to compare the efficacy of subcostal Transversus abdominis plane analgesia, to epidural analgesia intra and postoperatively in upper abdominal surgeries.
Detailed description
Epidural analgesia, once considered the gold standard for major abdominal surgeries, but is often associated with sympathetic blockade that creates hypotension and could therefore adversely affect the conduit. Epidural analgesia is recently replaced by other techniques with an improved risk benefit ratio. Pain management techniques that use peripheral nerve blockade are becoming more prevalent, reducing the need for an epidural. Transversus abdominis plane (TAP) approach is aimed to access the nerves in this neurofacial plane between internal oblique muscle and transversus abdominis through the lumbar triangle of Petit. Subcostal Transversus abdominis plane block, has been reported to provide analgesia for incisions extending above the umbilicus. However, there have been few clinical trials on the analgesic efficacy of continuous subcostal Transversus abdominis plane analgesia after major abdominal surgeries. It has been reported recently that supplemental magnesium has a role in providing perioperative analgesia, because this is a relatively harmless molecule, not expensive and because the biological basis for its potential antinociceptive effect is promising. No clinical studies have examined the effect of magnesium sulphate administered continuously in subcostal Transversus abdominis plane catheters as an adjunct to bupivacaine in postoperative analgesia. The aim of this study is to compare the efficacy of subcostal Transversus abdominis plane analgesia, to epidural analgesia in major upper abdominal surgeries.
Interventions
OTHERSubcostal Transversus Abdominis Plane catheter
Prior to surgery, an ultrasound guided unilateral Subcostal Transversus abdominis plane bolus dose (consisting of amixture of 10 ml bupivaccaine 0.5% plus 100 mg magnesium sulphate to be completed by normal saline to a total volume of 20 ml mixture) will be given on the same side of the surgical incision. At the end of surgery, A Transversus abdominis plane catheter will be inserted unilaterally by surgeon during wound closure. Then postoperatively, Transversus abdominis plane infusion of a solution mixture prepared in multiple 50 cm syringes each syringe contain 20 ml bupivacaine 0.5% plus 100 mg magnesium sulphate to be balanced by normal saline to 50 ml solution mixture ( final concentration of bupivacaine is 0.2%). This solution mixture will be infused through Transversus abdominis plane catheter at a rate of 6 ml/hour for 72 hours postoperatively.
OTHEREpidural catheter
Prior to surgery, we will site an epidural catheter in the thoracic T7-T9 region, and inject an epidural bolus dose same as described above (consisting of amixture of 10 ml bupivaccaine 0.5% plus 100 mg magnesium sulphate to be completed by normal saline to a total volume of 20 ml mixture) for intra operative analgesia. Postoperatively, patients will receive epidural infusion of the solution mixture (same as described above) prepared in multiple 50 cm syringes each syringe contain 20 ml bupivaccaine 0.5% plus 100 mg magnesium sulphate to be balanced by normal saline to 50 ml solution mixture ( final concentration of bupivaccaine is 0.2%). This solution mixture will be infused epidurally at a rate of 6 ml/hour for 72 hours (3 days) postoperatively.
Sponsors
Mansoura University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Investigator)
Intervention model description
Double blind (participant, investigator) study
Eligibility
Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No
Inclusion criteria
* American Society of Anesthesiologists (ASA) physical status I, II or III * The incision included is right subcostal incision for major upper abdominal surgeries (partial hepatectomy, pancreatic surgery included Whipple's procedure, total pancreatectomy and distal pancreatectomy) and other operations using the same incision.
Exclusion criteria
* Patient refusal. * Hematological diseases. * Bleeding diseases. * Coagulation abnormality. * Local skin infection * Sepsis at site of the block. * Known hypersensitivity to the study drugs. * Body Mass Index \> 35 Kg/m2. * If the lower end of the incision extended below T10 (umbilicus). * If the incision extended laterally beyond the anterior axillary line or extended to pass the midline to the other side.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Total morphine consumption | For 72 hours after surgery | Intravenous morphine in adose of 0.05 mg/kg will be given if Visual Analogue Scale (VAS) is more than 30 mm in both groups and can be repeated every 15 minutes till Visual Analogue Scale become less than 3. Morphine administration will be ceased when the Visual Analogue Scale score \<30 mm on assessment or when over-sedation or respiratory depression occurred (a respiratory rate of \< 10 bpm). Doses given will be calculated daily and recorded. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Pain Scores | up to 72 hours postoperatively | * Presence and severity of pain will be assessed in All patients during rest and coughing using visual analogue scale (VAS). * Visual analogue scale (VAS) ranging from 0 to 10 while 0 as no pain and 10 as worst imaginable pain. * Presence and severity of pain will be assessed at 1, 2, 4, 8, 12, 24, 36, 48, 60 and 72 hours postoperatively. |
| Heart rate | for 72 hours postoperative | Heart rate will be assessed at 1, 2, 4, 8, 12, 24, 36, 48, 60 and 72 hours postoperatively. |
| Mean arterial blood pressure | for 72 hours postoperative | Mean arterial blood pressure will be assessed at 1, 2, 4, 8, 12, 24, 36, 48, 60 and 72 hours postoperatively. |
| Peripheral oxygen saturation | for 72 hours postoperative | Peripheral oxygen saturation will be assessed at 1, 2, 4, 8, 12, 24, 36, 48, 60 and 72 hours postoperatively. |
| First request for rescue analgesia | for 72 hours after surgery | First time patient ask for analgesia: in the post anesthesia care unit (PACU) will be recorded and morphine in a dose of 0.05 mg/kg will be given and the time recorded. |
| Degree of sedation | for 72 hours postoperative | Degree of sedation will be assessed by using the sedation scale described by Culebras (2001) as: * 1 : Awake and alert, * 2 : Sedated, responding to verbal stimulus, * 3 : Sedated, responding to mild physical stimulus, * 4 : Sedated, responding only to moderate or severe physical stimulus Degree of sedation will be assessed at 1, 2, 4, 8, 12, 24, 36, 48, 60 and 72 hours postoperatively |
| Serum level of magnesium sulphate | up to 72 hours postoperatively | Degree of sedation will be assessed by using the sedation scale described by Culebras (2001) as: * 1 : Awake and alert, * 2 : Sedated, responding to verbal stimulus, * 3 : Sedated, responding to mild physical stimulus, * 4 : Sedated, responding only to moderate or severe physical stimulus Degree of sedation will be assessed at 1, 2, 4, 8, 12, 24, 36, 48, 60 and 72 hours postoperatively |
| Patient satisfaction with their analgesia | up to 72 hours postoperatively | * Patient satisfaction with their analgesia will be assessed as (poor = 1, fair = 2, good = 3, excellent = 4). * Patient satisfaction with their analgesia will be assessed at 24, 48 and 72 hours post operatively. |
| Wound pain | up to 3 months postoperatively | * Residual or chronic wound pain will be assessed in All patients using visual analogue scale (VAS). * Visual analogue scale (VAS) ranging from 0 to 10 while 0 as no pain and 10 as worst imaginable pain. * Residual wound pain will be assessed at 30, 60, 90 days postoperatively. |
| Nausea and vomiting | up to 72 hours postoperatively | Nausea and vomiting: will be assessed through nausea scores (none = 0, mild = 1, moderate = 2 and vomiting = 3) at 1, 2, 4, 8, 12, 24, 36, 48, 60,72 hrs post operativly. We offered rescue antiemetics to any patient who had a nausea score of 2 or more. |
Countries
Egypt
Outcome results
None listed